Evaluation of gastric acid suppression with vonoprazan using calcium carbonate breath test
-
- Miyamoto Shuichi
- Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine
-
- Tsuda Momoko
- Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine
-
- Kato Mototsugu
- Department of Gastroenterology, National Hospital Organization Hakodate Hospital
-
- Mabe Katsuhiro
- Department of Gastroenterology, National Hospital Organization Hakodate Hospital
-
- Muto Shuichi
- Department of Gastroenterology, National Hospital Organization Hokkaido Medical Center
-
- Ono Shoko
- Division of Endoscopy, Hokkaido University Hospital
-
- Shimizu Yuichi
- Division of Endoscopy, Hokkaido University Hospital
-
- Sakamoto Naoya
- Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine
Search this article
Abstract
<p>Vonoprazan, a potassium-competitive acid blocker, is a new class of acid-suppressing agent. The acid-inhibitory effect of vonoprazan has been well-documented. However, there is no report on the extent to which the amount of gastric acid secretion is suppressed, not pH measurement, by the use of vonoprazan. The aim of this study was to evaluate this suppression effect. This was a single-arm, interventional pilot study involving 7 healthy Japanese men. The subjects were administered 20 mg vonoprazan for 6 days. The amount of gastric acid secretion was determined using the calcium carbonate breath test. The acid outputs were defined as the maximum Δ13C‰ (Δ13C max) and area under the curve (AUC) during the 30 min sampling period. The Δ13C max and AUC values significantly decreased on the administration of 20 mg vonoprazan. The AUC dropped by approximately 78% on day 1 and by 84% on day 6 and subsequently returned to the control level after cessation of vonoprazan therapy (reduction by 68% on day 7 and by 42% on day 8). In conclusion, the amount of gastric acid secretion rapidly decreased by the administration of vonoprazan; this inhibitory effect was found to be potent and long-lasting. (UMIN ID: UMIN000025469)</p>
Journal
-
- Journal of Clinical Biochemistry and Nutrition
-
Journal of Clinical Biochemistry and Nutrition 64 (2), 174-179, 2019
SOCIETY FOR FREE RADICAL RESEARCH JAPAN
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001288125497344
-
- NII Article ID
- 130007605939
-
- ISSN
- 18805086
- 09120009
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed